CGE

Clopidogrel

Created: 2010-04-07
Last modified:  2021-03-13

Find related ligands:

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count1
Bond Count39
Aromatic Bond Count11
2D diagram of CGE

Chemical Component Summary

NameClopidogrel
Synonymsmethyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
Systematic Name (OpenEye OEToolkits)methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)ethanoate
FormulaC16 H16 Cl N O2 S
Molecular Weight321.822
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01Clc1ccccc1C(N3CCc2sccc2C3)C(=O)OC
SMILESCACTVS3.370COC(=O)[CH](N1CCc2sccc2C1)c3ccccc3Cl
SMILESOpenEye OEToolkits1.7.0COC(=O)C(c1ccccc1Cl)N2CCc3c(ccs3)C2
Canonical SMILESCACTVS3.370 COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl
Canonical SMILESOpenEye OEToolkits1.7.0 COC(=O)[C@H](c1ccccc1Cl)N2CCc3c(ccs3)C2
InChIInChI1.03 InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
InChIKeyInChI1.03 GKTWGGQPFAXNFI-HNNXBMFYSA-N

Drug Info: DrugBank

DrugBank IDDB00758 
NameClopidogrel
Groups approved
DescriptionClopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213] It has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and provides additional benefit to patients with acute coronary syndromes already taking aspirin.[A180547] Clopidogrel was granted FDA approval on 17 November 1997.[L7213]
Synonyms
  • Clopidogrel bisulfate
  • (+)-Clopidogrel
  • Clopidogrel hydrochloride
  • Clopidogrel
  • Clopidogrelum
Brand Names
  • Jamp-clopidogrel
  • Clopidogre Ratiopharm
  • Clopidogrel Tad
  • Priva-clopidogrel
  • Iscover
IndicationClopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]
Categories
  • Antiplatelet agents
  • Blood and Blood Forming Organs
  • Cytochrome P-450 CYP1A2 Substrates
  • Cytochrome P-450 CYP2B6 Inhibitors
  • Cytochrome P-450 CYP2B6 Inhibitors (moderate)
ATC-CodeB01AC04
CAS number113665-84-2

Drug Targets

NameTarget SequencePharmacological ActionActions
P2Y purinoceptor 12MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIF...unknownantagonist
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate,inhibitor
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
Cytochrome P450 2C8MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...unknowninhibitor
Liver carboxylesterase 1MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIF...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1771
PubChem 60606
ChEMBL CHEMBL1771
ChEBI CHEBI:37941
CCDC/CSD FUQMOU, RECJER